Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Dr Walter Henry Anderson (1870-1937) and the mission hospital at Safed, Palestine.

Stokes GS.

J Med Biogr. 2013 Feb;21(1):55-61. doi: 10.1258/jmb.2011.011029.

PMID:
23610230
2.

Management of hypertension in the elderly patient.

Stokes GS.

Clin Interv Aging. 2009;4:379-89. Epub 2009 Oct 12. Review.

3.

Treatment of isolated systolic hypertension.

Stokes GS.

Curr Hypertens Rep. 2006 Oct;8(5):377-83. Review.

PMID:
16965723
4.

Nitrates as adjunct hypertensive treatment.

Stokes GS.

Curr Hypertens Rep. 2006 Apr;8(1):60-8. Review.

PMID:
16600161
5.

Long-term effectiveness of extended-release nitrate for the treatment of systolic hypertension.

Stokes GS, Bune AJ, Huon N, Barin ES.

Hypertension. 2005 Mar;45(3):380-4. Epub 2005 Feb 7.

PMID:
15699445
6.

Systolic hypertension in the elderly: pushing the frontiers of therapy--a suggested new approach.

Stokes GS.

J Clin Hypertens (Greenwich). 2004 Apr;6(4):192-7. Review. Erratum in: J Clin Hypertens (Greenwich). 2004 Sep;6(9):508.

7.

Interactions of L-arginine, isosorbide mononitrate, and angiotensin II inhibitors on arterial pulse wave.

Stokes GS, Barin ES, Gilfillan KL, Kaesemeyer WH.

Am J Hypertens. 2003 Sep;16(9 Pt 1):719-24.

PMID:
12944028
8.

Effects of isosorbide mononitrate and AII inhibition on pulse wave reflection in hypertension.

Stokes GS, Barin ES, Gilfillan KL.

Hypertension. 2003 Feb;41(2):297-301.

PMID:
12574098
9.

Efficacy of an angiotensin II receptor antagonist in managing hyperaldosteronism.

Stokes GS, Monaghan JC, Ryan M, Woodward M.

J Hypertens. 2001 Jun;19(6):1161-5.

PMID:
11403366
10.

Influence of angiotensin converting enzyme (ACE) genotype on interpretation of diagnostic tests for serum ACE activity.

Stokes GS, Monaghan JC, Schrader AP, Glenn CL, Ryan M, Morris BJ.

Aust N Z J Med. 1999 Jun;29(3):315-8.

PMID:
10868493
11.
14.
15.
16.

Diet modification in lowering plasma cholesterol levels. A randomised trial of three types of intervention.

Johnston HJ, Jones M, Ridler-Dutton G, Spechler F, Stokes GS, Wyndham LE.

Med J Aust. 1995 May 15;162(10):524-6.

PMID:
7776913
17.

Interaction between Ca2+, verapamil, and ketanserin in rat tail artery and aorta.

Okoro EO, Marwood JF, Stokes GS.

J Cardiovasc Pharmacol. 1995 Apr;25(4):603-10.

PMID:
7596129
18.

Comparative and combined efficacy of doxazosin and enalapril in hypertensive patients.

Stokes GS, Johnston HJ, Okoro EO, Boutagy J, Monaghan JC, Marwood JF.

Clin Exp Hypertens. 1994 Nov;16(6):709-27.

PMID:
7858555
19.

Somatothymia in chronic pain patients.

Iezzi A, Stokes GS, Adams HE, Pilon RN, Ault L 3rd.

Psychosomatics. 1994 Sep-Oct;35(5):460-8.

PMID:
7972661
20.

Genotypic influence on plasma dipeptidyl carboxypeptidase-1 activity in hypertensives.

Morris BJ, Monaghan JC, Perich R, Stokes GS, Jackson B, Schrader AP.

Clin Exp Pharmacol Physiol. 1994 Apr;21(4):343-6.

PMID:
7923904
21.

Adolescent life experiences as predictors of occupational attainment.

Snell AF, Stokes GS, Sands MM, McBride JR.

J Appl Psychol. 1994 Feb;79(1):131-41.

PMID:
8200870
22.

Humoral determinants of Na+ excretion after intravenous NaCl loading in normal volunteers.

Stokes GS, Johnston HJ, Monaghan JC.

Clin Exp Pharmacol Physiol. 1993 May;20(5):310-2.

PMID:
8324915
23.

An Na, K ATPase inhibitor from ultrafiltrate obtained by hemodialysis of patients with uremia.

Sohn HJ, Stokes GS, Johnston H.

J Lab Clin Med. 1992 Aug;120(2):264-71.

PMID:
1323635
24.

Concurrence of primary aldosteronism and renal artery stenosis.

Stokes GS, Monaghan JC, Roche J, Grunstein H, Gordon RD.

Clin Exp Pharmacol Physiol. 1992 May;19(5):300-3.

PMID:
1521361
25.

Increase in serum total angiotensin-converting enzyme activity with enalapril therapy in humans: a controlled trial.

Stokes GS, Monaghan JC, Marwood JF, Okoro EO, Johnston H.

Clin Exp Pharmacol Physiol. 1992 May;19(5):297-9.

PMID:
1325880
26.

Effects of oral contraceptives containing oestrogen combined with norethisterone or levonorgestrel on erythrocyte cation transport in normal women.

Stokes GS, Monaghan JC, Flemming CL, Johnston H, Jones M, Pinkerton G, Baber R.

Clin Sci (Lond). 1992 May;82(5):505-12.

PMID:
1317759
27.

An identification of low back pain groups using biobehavioral variables.

Iezzi A, Adams HE, Stokes GS, Pilon RN, Ault LC.

J Occup Rehabil. 1992 Mar;2(1):19-33. doi: 10.1007/BF01078929.

PMID:
24242866
28.
29.

Effects of 17 alpha-ethinyl oestradiol in vitro on erythrocyte cation transport in men and women.

Monaghan JC, Flemming CL, Stokes GS.

Clin Exp Hypertens A. 1991;13(1):53-63.

PMID:
2022072
30.

The effects of sulindac and diclofenac in essential hypertension controlled by treatment with a beta blocker and/or diuretic.

Stokes GS, Brooks PM, Johnston HJ, Monaghan JC, Okoro EO, Kelly D.

Clin Exp Hypertens A. 1991;13(6-7):1169-78.

PMID:
1684743
31.

Effect of dialysis on circulating Na,K ATPase inhibitor in uremic patients.

Stokes GS, Norris LA, Marwood JF, Johnston H, Caterson RJ.

Nephron. 1990;54(2):127-33.

PMID:
2156180
32.

The pharmokinetics of isradipine in hypertensive subjects.

Shenfield GM, Boutagy J, Stokes GS, Rumble F, Dunagan F.

Eur J Clin Pharmacol. 1990;38(2):209-11.

PMID:
2140098
33.

Optimum drug treatment in hypertension.

Stokes GS.

J Cardiovasc Pharmacol. 1990;16 Suppl 7:S105-7. Review.

PMID:
1708005
34.

Timing of blood pressure measurements in determining anomalies in duration of effect of an antihypertensive drug: assessment of isradipine.

Stokes GS, Shenfield GM, Johnston HJ, Marwood JF, Dunagan F, Boutagy J.

J Cardiovasc Pharmacol. 1990;15 Suppl 1:S65-9.

PMID:
1695306
35.
36.

Life history prototypes in the study of human individuality.

Stokes GS, Mumford MD, Owens WA.

J Pers. 1989 Jun;57(2):509-45.

PMID:
2769565
37.

The effects of oestradiol administration on blood pressure and erythrocyte Na+ influx in oophorectomized rats.

Flemming CL, Marwood JF, Stokes GS.

Clin Exp Hypertens A. 1989;11(7):1235-48.

PMID:
2805360
38.

A.C.E. inhibitors and cough.

Stokes GS, Tugwell S, O'Neill ME, Hunyor SN, Pigott P.

Aust Fam Physician. 1988 Apr;17(4):275-6. No abstract available.

PMID:
2835029
39.

An Na+-K+-ATPase inhibitor which circulates in renal failure but not in essential hypertension.

Stokes GS, Norris LA, Marwood JF, Monaghan JC, Caterson RJ.

Prog Biochem Pharmacol. 1988;23:46-54. No abstract available.

PMID:
2847190
40.

Age-related effects of antihypertensive therapy with alpha-blockers.

Stokes GS.

J Cardiovasc Pharmacol. 1988;12 Suppl 8:S109-15. Review.

PMID:
2469891
41.

Angiotensin converting-enzyme inhibitor agents and respiratory symptoms.

Tugwell S, Stokes GS.

Med J Aust. 1987 Sep 7;147(5):263-4. No abstract available.

PMID:
2823085
42.

Erythrocyte cation fluxes during the menstrual cycle in normal female subjects.

Monaghan JC, Willcocks DA, Sinosich MJ, Stokes GS.

Clin Sci (Lond). 1987 Aug;73(2):223-6.

PMID:
3308285
43.

The Na+-H+ antiport in essential hypertension.

Stokes GS, Monaghan JC, Marwood JF.

Lancet. 1987 Jun 27;1(8548):1502. No abstract available.

PMID:
2885502
44.

Erythrocyte cation fluxes in the normotensive and hypertensive clients of a health screening clinic.

Stokes GS, Monaghan JC, Willcocks D, Jones MP, Marwood JF.

J Hypertens. 1987 Jun;5(3):285-91.

PMID:
3611777
45.

Measurement of circulating sodium-pump inhibitory activity in uraemia and essential hypertension.

Stokes GS, Willcocks D, Monaghan J, Boutagy J, Marwood JF.

J Hypertens Suppl. 1986 Dec;4(6):S376-8.

PMID:
2441015
46.

Studies that question the existence of alpha-2 adrenoceptors in tail arteries of normotensive Sprague-Dawley rats.

Marwood JF, Chapman KL, Stokes GS.

J Pharmacol Exp Ther. 1986 Jul;238(1):267-72.

PMID:
3014118
47.

Ketanserin and prazosin: a comparison of antihypertensive and biochemical effects.

Stokes GS, Mennie BA, Marwood JF.

Clin Pharmacol Ther. 1986 Jul;40(1):56-63.

PMID:
2941206
48.
49.

Studies on the vasodilator actions of bucindolol in the rat.

Marwood JF, Stokes GS.

Clin Exp Pharmacol Physiol. 1986 Jan;13(1):59-68.

PMID:
3708914
50.

Essential hypernatremia: disordered thirst and blood pressure control.

Brown MA, Mullins R, Stokes GS, Gy├Âry AZ.

Aust N Z J Med. 1985 Dec;15(6):751-4.

PMID:
3869442

Supplemental Content

Loading ...
Support Center